 GERMANTOWN, Md., Nov. 03, 2020 GLOBE NEWSWIRE -- Orgenesis Inc. NASDAQ: ORGS Orgenesis or the Company, a global biotech company working to unlock the full potential of cell and gene therapies, announced today that due to the public health impact of the COVID-19 pandemic and to support the health and well-being of its stockholders, the 2020 Annual Meeting, scheduled for November 18, 2020 at 10:00 am Eastern Time, will be held in a virtual format only. An in-person meeting will not be held this year. 